Steven M. Grunberg

13.7k total citations · 4 hit papers
156 papers, 9.9k citations indexed

About

Steven M. Grunberg is a scholar working on Surgery, Oncology and Physiology. According to data from OpenAlex, Steven M. Grunberg has authored 156 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Surgery, 40 papers in Oncology and 38 papers in Physiology. Recurrent topics in Steven M. Grunberg's work include Nausea and vomiting management (90 papers), Anesthesia and Pain Management (52 papers) and Pathogenesis and Treatment of Hiccups (25 papers). Steven M. Grunberg is often cited by papers focused on Nausea and vomiting management (90 papers), Anesthesia and Pain Management (52 papers) and Pathogenesis and Treatment of Hiccups (25 papers). Steven M. Grunberg collaborates with scholars based in United States, Italy and Denmark. Steven M. Grunberg's co-authors include Paul J. Hesketh, Richard J. Gralla, Mark G. Kris, William A. Haseltine, Matti Aapro, W. David Henner, Kevin Horgan, James M. Koeller, Alexandra D. Carides and Jørn Herrstedt and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Steven M. Grunberg

155 papers receiving 9.4k citations

Hit Papers

First-Line Gefitinib in Patients With Advanced Non–Small-... 1999 2026 2008 2017 2008 2003 2006 1999 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations
    2008 661 citations Steven M. Grunberg et al. Journal of Clinical Oncology profile →
  2. The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
    2003 593 citations Paul J. Hesketh, Steven M. Grunberg et al. Journal of Clinical Oncology profile →
  3. American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
    2006 516 citations Mark G. Kris, Paul J. Hesketh et al. Journal of Clinical Oncology profile →
  4. Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
    1999 483 citations Richard J. Gralla, Mark G. Kris et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven M. Grunberg United States 50 5.8k 3.1k 2.2k 1.5k 1.2k 156 9.9k
Paul J. Hesketh United States 51 8.3k 1.4× 3.9k 1.3× 2.4k 1.1× 1.6k 1.1× 598 0.5× 161 11.5k
Richard J. Gralla United States 64 6.8k 1.2× 3.1k 1.0× 6.8k 3.2× 5.6k 3.9× 2.1k 1.8× 294 16.2k
Karin Jordan Germany 33 2.0k 0.4× 961 0.3× 4.1k 1.9× 1.4k 0.9× 729 0.6× 112 7.4k
C S McArdle United Kingdom 45 2.8k 0.5× 654 0.2× 4.5k 2.1× 1.5k 1.0× 319 0.3× 157 7.7k
Paul F. Engstrom United States 41 1.4k 0.2× 1.7k 0.6× 3.5k 1.6× 1.4k 1.0× 713 0.6× 126 7.1k
Aminah Jatoi United States 50 1.9k 0.3× 5.8k 1.9× 4.6k 2.2× 2.6k 1.8× 2.4k 2.0× 400 13.6k
Robert J. Young United States 49 1.2k 0.2× 1.2k 0.4× 1.1k 0.5× 1.5k 1.1× 603 0.5× 232 9.4k
Mikael Rørth Denmark 49 2.5k 0.4× 756 0.2× 2.5k 1.2× 1.4k 1.0× 1.5k 1.2× 180 6.8k
Carlo DeAngelis Canada 34 1.4k 0.2× 528 0.2× 1.4k 0.6× 608 0.4× 317 0.3× 205 4.1k
Trinity J. Bivalacqua United States 57 5.7k 1.0× 1.3k 0.4× 1.4k 0.7× 1.9k 1.3× 2.3k 1.9× 478 15.3k

Countries citing papers authored by Steven M. Grunberg

Since Specialization
Citations

This map shows the geographic impact of Steven M. Grunberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Grunberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Grunberg more than expected).

Fields of papers citing papers by Steven M. Grunberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Grunberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Grunberg. The network helps show where Steven M. Grunberg may publish in the future.

Co-authorship network of co-authors of Steven M. Grunberg

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Grunberg. A scholar is included among the top collaborators of Steven M. Grunberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Grunberg. Steven M. Grunberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aapro, Matti, Jann Arends, Federico Bozzetti, et al.. (2014). Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Annals of Oncology. 25(8). 1492–1499. 231 indexed citations
2.
Cardoso, Fátima, Nuran Beşe, Sandra R. Distelhorst, et al.. (2013). Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. The Breast. 22(5). 593–605. 53 indexed citations
3.
Grunberg, Steven M., Barbara S. Slusher, & Hope S. Rugo. (2013). Emerging treatments in chemotherapy-induced nausea and vomiting.. PubMed. 11(2 Suppl 1). 1–18; quiz 2 p following 18. 20 indexed citations
4.
Avritscher, Elenir B.C., Ya‐Chen Tina Shih, Charlotte C. Sun, et al.. (2010). Cost–Utility Analysis of Palonosetron-Based Therapy in Preventing Emesis Among Breast Cancer Patients. PubMed. 8(6). 242–251. 16 indexed citations
5.
Kris, Mark G., Maurizio Tonato, Emilio Bria, et al.. (2010). Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy. Supportive Care in Cancer. 19(S1). 25–32. 27 indexed citations
6.
Einhorn, Lawrence H., Steven M. Grunberg, Bernardo L. Rapoport, Cynthia N. Rittenberg, & Petra Feyer. (2010). Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement. Supportive Care in Cancer. 19(S1). 1–4. 24 indexed citations
7.
Roila, Fausto, Janusz Rolski, Rodryg Ramlau, et al.. (2009). Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomiting. Annals of Oncology. 20(11). 1867–1873. 27 indexed citations
8.
9.
Grunberg, Steven M.. (2008). Giving Permission. Journal of Clinical Oncology. 26(33). 5477–5478. 4 indexed citations
10.
Grunberg, Steven M.. (2006). Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis. Annals of Oncology. 18(2). 233–240. 112 indexed citations
11.
Spitz, Irving M., et al.. (2005). Management of patients receiving long-term treatment with mifepristone. Fertility and Sterility. 84(6). 1719–1726. 48 indexed citations
12.
Einhorn, Lawrence H., Bernardo L. Rapoport, Jim M. Koeller, et al.. (2004). Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement. Supportive Care in Cancer. 13(2). 112–116. 26 indexed citations
13.
Grunberg, Steven M., et al.. (2004). Prevention of delayed nausea and vomiting (D-CINV): Carryover effect analysis of pooled data from 2 phase III studies of palonosetron (PALO). Journal of Clinical Oncology. 22(14_suppl). 8051–8051. 4 indexed citations
14.
Horgan, Kevin, Steven M. Grunberg, Paul J. Hesketh, et al.. (2003). 945 Analysis of pooled data from two Phase III studies of the NK-1 antagonist aprepitant to assess relationships between the incidence and control of cisplatin-induced acute vomiting and delayed vomiting. European Journal of Cancer Supplements. 1(5). S284–S285. 5 indexed citations
15.
Sapozink, Michael D., et al.. (2000). Unresectable Primary and Recurrent Head and Neck Tumors: Effect of Hyperthermia and Carboplatin—Preliminary Experience. Radiology. 214(3). 688–692. 4 indexed citations
16.
Grunberg, Steven M.. (1997). Innovative approaches in the treatment of emesis. Supportive Care in Cancer. 5(1). 9–11. 4 indexed citations
17.
Grunberg, Steven M.. (1992). The role of progesterone receptors in meningioma. Cancer treatment and research. 58. 127–137. 12 indexed citations
18.
Parker, R. J., Robert E. Tarone, Justine Vionnet, et al.. (1991). Platinum—DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry. Carcinogenesis. 12(7). 1253–1258. 66 indexed citations
19.
Grunberg, Steven M., Martin H. Weiss, Irving M. Spitz, et al.. (1991). Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. Journal of neurosurgery. 74(6). 861–866. 294 indexed citations
20.
Hoff, Daniel D. Von, Barbara Metch, Joel G. Lucas, et al.. (1990). Phase II Evaluation of Recombinant Interferon-β (LFN-β ser ) in Patients with Diffuse Mesothelioma: A Southwest Oncology Group Study. Journal of Interferon Research. 10(5). 531–534. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul J. Hesketh Breakdown of academic impact, for papers by Richard J. Gralla Breakdown of academic impact, for papers by Karin Jordan Breakdown of academic impact, for papers by C S McArdle Breakdown of academic impact, for papers by Paul F. Engstrom Breakdown of academic impact, for papers by Aminah Jatoi Breakdown of academic impact, for papers by Robert J. Young Breakdown of academic impact, for papers by Mikael Rørth Breakdown of academic impact, for papers by Carlo DeAngelis Breakdown of academic impact, for papers by Trinity J. Bivalacqua
Rankless by CCL
2026